Alemtuzumab and de novo pulmonary arterial hypertension: A potential association?

MeSH terms

• Aged
• Alemtuzumab / adverse effects*
• Alemtuzumab / therapeutic use
• Antineoplastic Agents, Immunological / adverse effects
• Antineoplastic Agents, Immunological / therapeutic use
• Humans
• Hypertension, Pulmonary / chemically induced*
• Hypertension, Pulmonary / physiopathology
• Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
• Male
• Pulmonary Wedge Pressure / drug effects*
• Risk Factors